WO1989000571A3 - Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation - Google Patents

Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation Download PDF

Info

Publication number
WO1989000571A3
WO1989000571A3 PCT/US1988/002375 US8802375W WO8900571A3 WO 1989000571 A3 WO1989000571 A3 WO 1989000571A3 US 8802375 W US8802375 W US 8802375W WO 8900571 A3 WO8900571 A3 WO 8900571A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceuticals
bicyclic compounds
intermediates useful
compounds
Prior art date
Application number
PCT/US1988/002375
Other languages
English (en)
Other versions
WO1989000571A2 (fr
Inventor
David J Blythin
Ho-Jane Shue
Dinesh Gala
Martin Steinman
Ashit Ganguly
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/076,469 external-priority patent/US4782067A/en
Priority claimed from US07/178,176 external-priority patent/US4897487A/en
Application filed by Schering Corp filed Critical Schering Corp
Priority to JP63506716A priority Critical patent/JPH07116187B2/ja
Priority to KR1019890700497A priority patent/KR940006285B1/ko
Publication of WO1989000571A2 publication Critical patent/WO1989000571A2/fr
Publication of WO1989000571A3 publication Critical patent/WO1989000571A3/fr
Priority to DK015590A priority patent/DK15590A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention décrit des composés bicycliques utiles comme agents anti-allergiques, anti-inflammatoires et/ou cytoprotecteurs et utiles dans le traitement des affections de la peau hyperprolifératives. Des compositions pharmaceutiques et des procédés de traitement utilisant de tels composés sont également décrits. Un grand nombre de ces composés sont nouveaux; des procédés originaux pour leur préparation et pour la préparation de composés intermédiaires sont également décrits.
PCT/US1988/002375 1987-07-22 1988-07-20 Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation WO1989000571A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP63506716A JPH07116187B2 (ja) 1987-07-22 1988-07-20 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
KR1019890700497A KR940006285B1 (ko) 1987-07-22 1988-07-20 이환식 화합물, 이의 제조방법 및 이의 제조에 유용한 중간체
DK015590A DK15590A (da) 1987-07-22 1990-01-19 Bicycliske forbindelser, deres anvendelse som farmaceutica, deres fremstilling og mellemprodukter anvendelige til deres fremstilling

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/076,469 US4782067A (en) 1985-07-29 1987-07-22 Anti-allergic composition containing zwitterionic bicyclic compounds
US07/076,450 US4794116A (en) 1985-07-29 1987-07-22 Anti-allergic esters, acetal ethers, thioethers and nitrogen substituted derivatives of bicyclic compounds
US076,469 1988-04-06
US07/178,176 US4897487A (en) 1988-04-06 1988-04-06 Process for preparing intermediates for pharmaceutically useful bicyclic compounds
US076,450 1988-04-06
US178,176 1988-04-06

Publications (2)

Publication Number Publication Date
WO1989000571A2 WO1989000571A2 (fr) 1989-01-26
WO1989000571A3 true WO1989000571A3 (fr) 1989-03-09

Family

ID=27372891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/002375 WO1989000571A2 (fr) 1987-07-22 1988-07-20 Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation

Country Status (8)

Country Link
EP (2) EP0362299A1 (fr)
JP (1) JPH07116187B2 (fr)
AU (1) AU632461B2 (fr)
DK (1) DK15590A (fr)
IL (1) IL87186A0 (fr)
MY (1) MY103593A (fr)
NZ (1) NZ225509A (fr)
WO (1) WO1989000571A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3911064A1 (de) * 1989-04-06 1990-10-11 Bayer Ag Substituierte 1,8-naphthyridine
CA2070400A1 (fr) * 1989-12-04 1991-06-05 David J. Blythin Naphthyridinones a substituants heterocycliques et methodes et compositions les utilisant
ES2094772T3 (es) * 1990-06-01 1997-02-01 Kyowa Hakko Kogyo Kk Derivados de imidazonaftiridinas.
US5760034A (en) * 1990-11-30 1998-06-02 Schering Corporation Heterocyclic substituted naphthyridinones and methods and compositions employing them
GB9127252D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374264A (en) * 1962-10-04 1968-03-19 Hoffmann La Roche N-haloacetyl-anthranilic acids and esters
EP0092786B1 (fr) * 1982-04-26 1987-01-07 Schering Corporation Dérivés de la 1,8-naphtyridine et de la 1,5,8-azanaphtyridine
WO1987000752A2 (fr) * 1985-07-29 1987-02-12 Schering Corporation Composes bicycliques amphoteriques et leurs sels, solvats, hydrates et esters

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5854152B2 (ja) * 1976-03-25 1983-12-02 久光製薬株式会社 新規なナフチリジン誘導体
US4452800A (en) * 1982-04-26 1984-06-05 Schering Corporation Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
NZ218774A (en) * 1986-01-06 1990-06-26 Carpibem 3-substituted phenylnaphthyridines and pharmaceutical compositions
JPS63159382A (ja) * 1986-10-15 1988-07-02 シェリング・コーポレーション １−置換ナフチリジンおよびピリドピラジン誘導体
CA1305478C (fr) * 1986-11-06 1992-07-21 Margaret H. Sherlock Composes naphthyridine et pyridopyrazine et leur utilisation pharmaceutique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374264A (en) * 1962-10-04 1968-03-19 Hoffmann La Roche N-haloacetyl-anthranilic acids and esters
EP0092786B1 (fr) * 1982-04-26 1987-01-07 Schering Corporation Dérivés de la 1,8-naphtyridine et de la 1,5,8-azanaphtyridine
WO1987000752A2 (fr) * 1985-07-29 1987-02-12 Schering Corporation Composes bicycliques amphoteriques et leurs sels, solvats, hydrates et esters

Also Published As

Publication number Publication date
EP0362299A1 (fr) 1990-04-11
MY103593A (en) 1993-08-28
EP0302303A2 (fr) 1989-02-08
WO1989000571A2 (fr) 1989-01-26
DK15590D0 (da) 1990-01-19
AU632461B2 (en) 1993-01-07
JPH02503675A (ja) 1990-11-01
JPH07116187B2 (ja) 1995-12-13
IL87186A0 (en) 1988-12-30
AU2253088A (en) 1989-02-13
NZ225509A (en) 1992-12-23
EP0302303A3 (fr) 1989-05-24
DK15590A (da) 1990-01-19

Similar Documents

Publication Publication Date Title
AU7820191A (en) New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
AU6194894A (en) Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
CA2272705A1 (fr) Derives de pyrimidines bicycliques fusionnes
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
AU2843689A (en) 2-(2-hydroxy-3-phenoxypropylamino) ethylphenoxymethyl compounds
SE9702001D0 (sv) Novel compounds
CA2091360A1 (fr) Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
IE861997L (en) Zwitterionic bicyclic compounds
AU1082988A (en) 5-hydroxy-3-aminochroman compounds, processes for their preparation, pharmaceutical compositions containing them and methods of treatment therewith
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
CA2163197A1 (fr) Triples complexes de platine
AU8315287A (en) New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same
JPS6438086A (en) Mevalonic acid derivative and manufacture
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
WO1989000571A3 (fr) Composes bicycliques, leur utilisation comme produits pharmaceutiques, leur preparation et composes intermediaires utiles dans leur preparation
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
AU660296B2 (en) Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same
EP0386920A3 (fr) Dérivés d'hydroxy-2-thiénylox-3-propylamine
AU8844091A (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
HRP960076B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK JP KR

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK JP KR

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988906692

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988906692

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988906692

Country of ref document: EP